OneMedNet Corporation (NASDAQ:ONMD – Get Free Report) Director Eric Casaburi acquired 10,000 shares of the business’s stock in a transaction dated Wednesday, October 15th. The shares were acquired at an average cost of $3.05 per share, with a total value of $30,500.00. Following the transaction, the director owned 65,475 shares in the company, valued at approximately $199,698.75. This trade represents a 18.03% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.
OneMedNet Price Performance
NASDAQ:ONMD opened at $1.72 on Friday. OneMedNet Corporation has a one year low of $0.30 and a one year high of $4.22. The business has a fifty day moving average price of $1.80 and a 200-day moving average price of $1.00. The firm has a market capitalization of $87.47 million, a price-to-earnings ratio of -34.30 and a beta of 1.09.
OneMedNet (NASDAQ:ONMD – Get Free Report) last released its quarterly earnings results on Friday, November 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business had revenue of $0.18 million during the quarter.
Analyst Ratings Changes
Get Our Latest Analysis on OneMedNet
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Correct Capital Wealth Management purchased a new stake in OneMedNet during the 3rd quarter valued at approximately $4,910,000. Ashton Thomas Private Wealth LLC bought a new position in shares of OneMedNet during the third quarter worth $25,000. Finally, Exencial Wealth Advisors LLC grew its stake in OneMedNet by 141.3% during the third quarter. Exencial Wealth Advisors LLC now owns 3,599,460 shares of the company’s stock valued at $3,923,000 after acquiring an additional 2,107,598 shares in the last quarter. 0.95% of the stock is currently owned by institutional investors.
About OneMedNet
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences.
Further Reading
- Five stocks we like better than OneMedNet
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Power On: Applied Digital’s First AI Data Center Goes Live
- What is Insider Trading? What You Can Learn from Insider Trading
- Alphabet: The AI Leader Best Positioned to Dominate 2026
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- 2 Reasons to Load Up on Fiserv, 1 to Stay Away
Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.
